The National Pharmacy Association has called for clear guidance on the sale of CBD products.
Health promotion in pharmacies “probably” improves patient health outcomes while being cost-effective, says Cochrane.
Pharmacists assessing needle use in diabetics helped Isle of Wight CCG make an annual saving of £44,000.
The GPhC has approved new guidance for pharmacist prescribers.
EHC should be reclassified as GSL and “sold off the shelf without consultation,” the RCOG has said.
Researchers say the NMS will save the NHS in England £651m and give patients almost 300,000 ‘quality adjusted life years’.
Pharmacy teams are raising awareness of the risks associated with valproate medicines and pregnancy – but more needs to be done.
CCA and AIM want community pharmacies to take part in an audit on the non-supply of OTC medicines to patients seeking self-care.
A number of pharmacies have reported being “surprised” at some of the CPCS cases referred to them by NHS 111 call handlers.
PharmOutcomes and GP practices using SystmOne trial electronic notifications.
This latest recall follows recalls of ranitidine products on 8 October, 17 October, 25 October and 19 November.
Flu vaccinations at 85pc of 2018-19 levels by early November.
The PDA is concerned about the unsafe practice of GP practice pharmacists.
Research published to coincide with Self Care Week has called for an evidence review of OTC analgesics.
Some 23 per cent of CCGs do not have integrated mental and physical health services in their area, according to Diabetes UK’s FOI request.
As Ask Your Pharmacist Week kicks off for 2019 the National Pharmacy Association (NPA) says: “it is more important than ever”.
The leadership of primary care networks is dominated by doctors, with other primary care professionals almost entirely absent.
The cross-sector Community Pharmacy Patient Safety Group has developed new medicines safety audit guidance.
The Community Pharmacy Patient Safety Group and PSNC release two pharmacy quality scheme resources.
The DHSC has extended the end date of the serious shortage protocols (SSPs) for Fluoxetine 30mg and 40mg capsules.